City of Hope scientists develop targeted chemotherapy able to kill all solid tumors in preclinical research

/PRNewswire/ -- Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, today published a new study...

The City of Hope-developed investigational small molecule selectively disrupts DNA replication and repair in cancer cells, leaving healthy cells unaffected, a new study reports. LOS ANGELES , Aug. 1, 2023 /PRNewswire/ -- Researchers at City of Hope , one of the largest cancer research and treatment organizations in the United States , today published a new study explaining how they took a protein once thought to be too challenging for targeted therapy, proliferating cell nuclear antigen (PCNA), and developed a targeted chemotherapy that appears to annihilate all solid tumors in preclinical res

related reading

• Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
• Targeting telomerase for cancer therapy | Oncogenenature.com
• Medicine's Endgamenotboring.co
• Has pancreatic cancer met its match?worksinprogress.co
• Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
• The blood cancer that became solvableworksinprogress.news
• Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designationmed.stanford.edu
• The current state of the art and future trends in RAS-targeted cancer therapiesnature.com
• Engineering proteins to treat cancer | MIT News | Massachusetts Institute of Technologynews.mit.edu
• Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
• Google’s Gemma AI model helps discover new potential cancer therapy pathwayblog.google
• Summing up cancer stem cellsnature.com